Protagonist Therapeutics, Inc

Bank of New York Mellon Corp PTGX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

350,388

Value ($000)

30,603

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	30,603	0.0%	350,388	12/31/2025
2025 Q3	11/3/2025	24,131	0.0%	363,261	9/30/2025
2025 Q2	8/5/2025	21,449	0.0%	388,082	6/30/2025
2025 Q1	4/29/2025	18,225	0.0%	376,863	3/31/2025
2024 Q4	2/4/2025	15,084	0.0%	390,788	12/31/2024
2024 Q3	11/12/2024	16,035	0.0%	356,333	9/30/2024
2024 Q2	7/25/2024	7,079	0.0%	204,299	6/30/2024
2024 Q1	4/25/2024	5,417	0.0%	187,234	3/31/2024
2023 Q4	1/29/2024	4,659	0.0%	203,177	12/31/2023
2023 Q3	10/24/2023	3,360	0.0%	201,444	9/30/2023
2023 Q2	8/3/2023	5,512	0.0%	199,575	6/30/2023
2023 Q1	5/9/2023	3,876	0.0%	168,533	3/31/2023
2022 Q4	2/14/2023	1,793	0.0%	164,325	12/31/2022
2022 Q3	11/14/2022	1,332	0.0%	158,059	9/30/2022
2022 Q2	8/15/2022	1,124	0.0%	142,071	6/30/2022
2022 Q1	5/11/2022	3,310	0.0%	139,769	3/31/2022
2021 Q4	2/11/2022	4,736	0.0%	138,494	12/31/2021
2021 Q3	11/18/2021	2,324	0.0%	131,133	9/30/2021
2021 Q2	8/11/2021	6,567	0.0%	146,330	6/30/2021
2021 Q1	5/13/2021	3,460	0.0%	133,595	3/31/2021
2020 Q4	2/9/2021	2,607	0.0%	129,304	12/31/2020
2020 Q3	11/12/2020	1,847	0.0%	94,454	9/30/2020
2020 Q2	8/12/2020	1,790	0.0%	101,352	6/30/2020
2020 Q1	5/6/2020	590	0.0%	83,583	3/31/2020
2019 Q4	2/14/2020	589	0.0%	83,582	12/31/2019